Upstate Active Clinical Trials

Study Title:

A phase II, observer-blind, randomized, controlled study to evaluate the immunogenicity and safety of a varicella vaccine at various potencies compared with Varivax, as a first dose, administered in healthy children in their second year of life.

What is the purpose of the study? (in Layman's terms, please describe the study)

A study on the immune response and safety of various potencies of an investigational chickenpox vaccine compared with a marketed chickenpox vaccine, given to healthy children 12 to 15 months of age.

Upstate Institutional Review Board (IRB) Number:

1840395

Study/Protocol ID:

217212

Study Phase:

Phase II

Patient Age Group:

Children

Principal Investigator:

Joseph B Domachowske

What is involved if I participate?

• How long is the study?
  Roughly 6 months
• Is transportation provided or reimbursed?
  Yes
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  One 3mL blood draw collection for an antibody determination test 43 days after the study intervention is given

Where will the study take place?

Nappi Wellness institute
725 E. Adams St,
Syracuse, NY 13210

Other Information:

N/A

ClinicalTrials.Gov ID:

NCT05084508

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Nishat Anwar, MD,MPH
Phone: 315-464-7505
Email: [email protected]

Return to Previous Page || Search Again